Inés de Torres

4.1k total citations
119 papers, 3.0k citations indexed

About

Inés de Torres is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Inés de Torres has authored 119 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Surgery, 40 papers in Pulmonary and Respiratory Medicine and 33 papers in Molecular Biology. Recurrent topics in Inés de Torres's work include Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Inés de Torres is often cited by papers focused on Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Inés de Torres collaborates with scholars based in Spain, United States and Palestinian Territory. Inés de Torres's co-authors include María Vicario, Carmen Alonso, Cristina Martínez, Mar Guilarte, Javier Santos, Juan Moróte, Esteban Saperas, Laura Ramos, Francesc Casellas and Beatriz Lobo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Inés de Torres

117 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inés de Torres Spain 28 1.0k 889 877 586 482 119 3.0k
Hagen Blaszyk United States 36 1.3k 1.3× 921 1.0× 1.3k 1.5× 675 1.2× 1.2k 2.4× 90 4.1k
Uwe J. Roblick Germany 28 860 0.8× 472 0.5× 942 1.1× 317 0.5× 880 1.8× 94 2.9k
Luca Mastracci Italy 34 1.3k 1.3× 844 0.9× 621 0.7× 717 1.2× 1.2k 2.4× 183 3.6k
Masahiro Fukuzawa Japan 31 1.4k 1.3× 303 0.3× 1.4k 1.6× 805 1.4× 592 1.2× 197 3.6k
Juan Lechago United States 34 1.9k 1.8× 384 0.4× 1.0k 1.2× 1.0k 1.7× 588 1.2× 107 4.0k
Marie E. Robert United States 36 1.9k 1.8× 622 0.7× 602 0.7× 1.1k 1.9× 864 1.8× 114 4.6k
Nobuhiko Oridate Japan 32 990 1.0× 158 0.2× 1.1k 1.3× 678 1.2× 711 1.5× 208 3.1k
Laura Villani Italy 33 1.5k 1.5× 538 0.6× 959 1.1× 635 1.1× 1.1k 2.2× 105 3.9k
Nobuo Hiwatashi Japan 33 1.0k 1.0× 394 0.4× 391 0.4× 408 0.7× 399 0.8× 126 3.4k
Jean Closset Belgium 34 1.5k 1.5× 215 0.2× 758 0.9× 738 1.3× 1.0k 2.1× 158 3.8k

Countries citing papers authored by Inés de Torres

Since Specialization
Citations

This map shows the geographic impact of Inés de Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inés de Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inés de Torres more than expected).

Fields of papers citing papers by Inés de Torres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inés de Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inés de Torres. The network helps show where Inés de Torres may publish in the future.

Co-authorship network of co-authors of Inés de Torres

This figure shows the co-authorship network connecting the top 25 collaborators of Inés de Torres. A scholar is included among the top collaborators of Inés de Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inés de Torres. Inés de Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcı́a, Javier Garcı́a, A. Celma, Juan Moróte, et al.. (2024). Association of the rs1042522 SNP with prostate cancer risk: a study of cancer tissues, primary tumor cultures, and serum samples from a Spanish Caucasian population. Frontiers in Oncology. 14. 1398411–1398411. 2 indexed citations
2.
Regis, Lucas, A. Celma, Inés de Torres, et al.. (2023). Relationship between Proclarix and the Aggressiveness of Prostate Cancer. Molecular Diagnosis & Therapy. 27(4). 487–498. 2 indexed citations
3.
Moróte, Juan, Lucas Regis, A. Celma, et al.. (2022). Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?. The International Journal of Biological Markers. 37(2). 218–223. 3 indexed citations
4.
Moróte, Juan, Lucas Regis, A. Celma, et al.. (2022). Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI. Cancers. 14(11). 2702–2702. 4 indexed citations
5.
6.
Moróte, Juan, A. Celma, Lucas Regis, et al.. (2022). The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer. The World Journal of Men s Health. 40(2). 270–270. 9 indexed citations
7.
Oliván, Mireia, Marta García, Marc Guiu, et al.. (2021). Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples. Cancers. 13(24). 6202–6202. 11 indexed citations
8.
Gómez, Valentí, Inés de Torres, Juan Moróte, et al.. (2019). A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells. Cancer Letters. 452. 158–167. 4 indexed citations
9.
Borque‐Fernando, Ángel, Luis Esteban, A. Celma, et al.. (2019). How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies. World Journal of Urology. 38(6). 1481–1491. 8 indexed citations
10.
Vilardell, Jordi, Eduard Sarró, Thaïs Cuadros, et al.. (2017). Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival. Oncotarget. 9(5). 5736–5751. 15 indexed citations
11.
Cuadros, Thaïs, Eduard Sarró, Maya R. Vilà, et al.. (2014). HAVCR/KIM-1 Activates the IL-6/STAT-3 Pathway in Clear Cell Renal Cell Carcinoma and Determines Tumor Progression and Patient Outcome. Cancer Research. 74(5). 1416–1428. 76 indexed citations
12.
Vicario, María, Ana María González-Castro, Cristina Martínez, et al.. (2014). Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations. Gut. 64(9). 1379–1388. 90 indexed citations
13.
Sesé, Marta, Yolanda Fernández, Ibane Abasolo, et al.. (2014). Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression. Molecular Cancer. 13(1). 74–74. 30 indexed citations
14.
Moróte, Juan, A. Celma, Jacques Planas, et al.. (2014). Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness. International Journal of Molecular Sciences. 15(8). 13615–13623. 25 indexed citations
15.
Rigau, Marina, Mireia Oliván, Marta García, et al.. (2013). The Present and Future of Prostate Cancer Urine Biomarkers. International Journal of Molecular Sciences. 14(6). 12620–12649. 56 indexed citations
16.
Barbosa-Desongles, Anna, Cristina Hernández, Inés de Torres, et al.. (2013). Diabetes Protects from Prostate Cancer by Downregulating Androgen Receptor: New Insights from LNCaP Cells and PAC120 Mouse Model. PLoS ONE. 8(9). e74179–e74179. 22 indexed citations
17.
Martínez, Cristina, Beatriz Lobo, Marc Pigrau, et al.. (2012). Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut. 62(8). 1160–1168. 231 indexed citations
18.
López-Vicente, Laura, Gemma Armengol, Matilde E. Lleonart, et al.. (2009). Regulation of Replicative and Stress-Induced Senescence by RSK4, which is Down-regulated in Human Tumors. Clinical Cancer Research. 15(14). 4546–4553. 37 indexed citations
19.
20.
Schwartz, Simó, et al.. (1998). Over-expression of epidermal growth factor receptor and c-erbB2/neu but not ofint-2 genes in benign prostatic hyperplasia by means of semi-quantitative PCR. International Journal of Cancer. 76(4). 464–467. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hagen Blaszyk Breakdown of academic impact, for papers by Uwe J. Roblick Breakdown of academic impact, for papers by Luca Mastracci Breakdown of academic impact, for papers by Masahiro Fukuzawa Breakdown of academic impact, for papers by Juan Lechago Breakdown of academic impact, for papers by Marie E. Robert Breakdown of academic impact, for papers by Nobuhiko Oridate Breakdown of academic impact, for papers by Laura Villani Breakdown of academic impact, for papers by Nobuo Hiwatashi Breakdown of academic impact, for papers by Jean Closset
Rankless by CCL
2026